The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
05/15/2023 | Jamie Irvine | 2 min read
Modified screening process optimizes nanobodies for sustainable COVID-19 treatments derived from llamas.
04/19/2023 | Jamie Irvine | 2 min read
Researchers use genome mining and bioengineering techniques to develop sustainable saponin-based vaccine adjuvants
03/20/2023 | Joseph Payne | 8 min read
Why is self-amplifying mRNA gaining more and more attention in the vaccine space?
03/06/2023 | Rainer Lichtenberger | 8 min read
What are the lessons we must learn from the COVID-19 pandemic?
01/18/2023 | Stephanie Sutton | 3 min read
Anti-vaccine activists are suing a number of prominent media outlets, including Reuters, the Washington Post, the BBC, and the Associated Press.
01/10/2023 | Angus Stewart | 6 min read
In the face of war and the economic fallout of COVID-19, Europe is weathering an energy price storm. What does this mean for medicine makers?
12/20/2022 | Rob Coker | 4 min read
For any organization, one ill-timed tweet can create enormous backlash.
12/13/2022 | Angus Stewart
In the face of economic uncertainty in a post-pandemic world, how will the cell and gene field respond?
12/08/2022 | Angus Stewart | 3 min read
A year of turmoil, and a year of change – just how healthy are pharma and the life sciences?
10/27/2022
Watch our special roundtable to learn about pharma industry trends and events post-COVID-19.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
The Grand Winner
How Data Sharing Can Upgrade AI for Pharma
Welcome to the CRISPR Powerhouse